Description of Research Expertise:
Functional Tumor MR Imaging: DCE-MRI, DWI, MRSI
Morphologic Tumor Response Evaluation
Selected Publications:
Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM: MRI,
Clinical Examination, and Mammography for Preoperative Assessment of Residual
Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for
Breast Cancer: ACRIN 6657 Trial AJR Am J Roentgenol 210 (6): 1376-1385,2018.
Baumann BC, Wei J, Plastaras JP, Lukens JN, Damjanov N, Hoteit M, Hsu C, Levine M, Mondschein J, Nadolski G, Olthoff K, Reiss KA, Rosen M, Siegelman E, Metz JM, Ben-Josef E: Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity Am J Clin Oncol : 2018.
Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM: MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial J Magn Reson Imaging 46 (1): 290-302,2017.
Rosen M, Kinahan PE, Gimpel JF, Opanowski A, Siegel BA, Hill GC, Weiss L, Shankar L: Performance Observations of Scanner Qualification of NCI-Designated
Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program Acad Radiol 24 (2): 232-245,2017.
Bai HX, Lee AM, Rosen MA: Abdominal Pain in a Patient 13 Years After Roux-en-Y
Gastric Bypass Gastroenterology 150 (7): 1540-41,2016.
Hylton Nola M, Gatsonis Constantine A, Rosen Mark A, Lehman Constance D, Newitt David C, Partridge Savannah C, Bernreuter Wanda K, Pisano Etta D, Morris Elizabeth A, Weatherall Paul T, Polin Sandra M, Newstead Gillian M, Marques Helga S, Esserman Laura J, Schnall Mitchell D: Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology 279 (1): 44-55,2016.
Narayan Vivek, Hwang Wei-Ting, Lal Priti, Rosen Mark A, Gallagher Maryann, O'Dwyer Peter J, Vaughn David J: Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Unresectable Mature Teratoma: Long-Term Follow-Up of a Phase II Study. Clinical genitourinary cancer s1558-7673 (16): 30064-7,2016.
FitzGerald Thomas J, Bishop-Jodoin Maryann, Followill David S, Galvin James, Knopp Michael V, Michalski Jeff M, Rosen Mark A, Bradley Jeffrey D, Shankar Lalitha K, Laurie Fran, Cicchetti M Giulia, Moni Janaki, Coleman C Norman, Deye James A, Capala Jacek, Vikram Bhadrasain: Imaging and Data Acquisition in Clinical Trials for Radiation Therapy. International journal of radiation oncology, biology, physics 94 (2): 404-11,2016.
Singanamalli A, Rusu M, Sparks RE, Shih NN, Ziober A, Wang LP, Tomaszewski J, Rosen M, Feldman M, Madabhushi A: Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer J Magn Reson Imaging 43 (1): 149-58,2016.
Flaherty Keith T, Hamilton Betty K, Rosen Mark A, Amaravadi Ravi K, Schuchter Lynn M, Gallagher Maryann, Chen Helen, Sehgal Chandra, O'Dwyer Peter J: Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers. The Oncologist 20 (8): 952-9,2015.